• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTEGRAFT, INC. ARTEGRAFT; COLLAGEN VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTEGRAFT, INC. ARTEGRAFT; COLLAGEN VASCULAR GRAFT Back to Search Results
Model Number AG740
Device Problem Leak/Splash (1354)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/18/2018
Event Type  malfunction  
Manufacturer Narrative
Return of the complaint graft has been requested by artegraft, inc.For evaluation.The complaint artegraft (collagen vascular graft) lot number 17m381-020 has not yet been returned for further evaluation.Several attempts have been made to obtain the graft.Should the graft be returned, or additional information become available, a follow-up report will be submitted.No adverse events to the patient were reported.A review of the device history record was performed; no abnormalities were identified.All grafts released from batch 17m381 passed the requirements for release, including: wall thickness, pressure testing, and final visual inspection prior to release to finished goods.No directly related non-conformnaces were identified to the leaking graft complaint.To date, no additional complaints from the batch have been reported.The complaint issue will continue to be monitored within artegraft, inc.Quality assurance trending.
 
Event Description
Artegraft, inc.Received an electronic implant usage card with a note stating "graft is defective and will be picked up by vendor for evaluation".Additional information was received from an approved distributor representative on behalf of a vascular surgeon (dr.(b)(6)) explaining that the graft had leaked during the pre-implant pressure test per the corresponding artegraft, inc.Ifu.The surgeon did not implant the graft (17m381-020).No patient adverse events were reported.
 
Manufacturer Narrative
(b)(4) mdr 2247686-2018-00007 follow up 001.Complaint graft 17m381-020 was received by artegraft, inc for evaluation.A note was written on the returned box stating "clip in area where leak was" a qualified manufacturing technician visually inspected the graft to artegraft, inc.Release specifications.A severe injured wall was identified near where the graft was visibly "clipped" by the physician, while a second injured wall was identified next to the area.An injured graft wall would have been detected during the artegraft, inc.Manufacturing final visual inspection step prior to release of any graft.The injured wall areas identified may have been caused by manipulation of the graft and "clipping" that was conducted by the physician.Additional functional testing was not performed as defects were visually identified on the returned graft as well as a clear manipulation (clipped) after being opened at the customer site.As this is a known issue, artegraft, inc.Instructions for use include instructions for pressure testing each graft prior to implant, which was conducted by the physician.Returned to manufacturer on 10/25/2018.Date received by mfr: 10/25/2018.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTEGRAFT
Type of Device
COLLAGEN VASCULAR GRAFT
Manufacturer (Section D)
ARTEGRAFT, INC.
206 north center drive
north brunswick NJ 08902 4247
MDR Report Key7990809
MDR Text Key126229248
Report Number2247686-2018-00007
Device Sequence Number1
Product Code LXA
UDI-Device Identifier00316837000299
UDI-Public(01)00316837000299(17)210131(10)17M381-020
Combination Product (y/n)N
PMA/PMN Number
N16837
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/31/2021
Device Model NumberAG740
Device Catalogue NumberAG740
Device Lot Number17M381-020
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/25/2018
Date Manufacturer Received10/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age37 YR
-
-